Grande E - Search Results

1

Economics of gastroenteropancreatic neuroendocrine tumors: a systematic review.

Grande E, Díaz Á, López C, Munarriz J, Reina JJ, Vera R, Bernárdez B, Aller J, Capdevila J, Garcia-Carbonero R, Jimenez Fonseca P, Trapero-Bertran M. Grande E, et al. Ther Adv Endocrinol Metab. 2019 Feb 18;10:2042018819828217. doi: 10.1177/2042018819828217. eCollection 2019. Ther Adv Endocrinol Metab. 2019. PMID: 30815246 Free PMC article. Review.

2

Recommendations and expert opinion on the adjuvant treatment of colon cancer in Spain.

Vieitez JM, García-Carbonero R, Aparicio J, Feliu J, González-Flores E, Grande E, Pérez-Hoyos T, Salud A, Torres E, Valero M, Valladares-Ayerbes M, Díaz-Rubio E. Vieitez JM, et al. Among authors: grande e. Clin Transl Oncol. 2011 Nov;13(11):798-804. doi: 10.1007/s12094-011-0736-4. Clin Transl Oncol. 2011. PMID: 22082644

3

Gastroenteropancreatic neuroendocrine tumor cancer stem cells: do they exist?

Grande E, Capdevila J, Barriuso J, Antón-Aparicio L, Castellano D. Grande E, et al. Cancer Metastasis Rev. 2012 Jun;31(1-2):47-53. doi: 10.1007/s10555-011-9328-6. Cancer Metastasis Rev. 2012. PMID: 22105614 Review.

4

Sorafenib in metastatic thyroid cancer.

Capdevila J, Iglesias L, Halperin I, Segura A, Martínez-Trufero J, Vaz MÁ, Corral J, Obiols G, Grande E, Grau JJ, Tabernero J. Capdevila J, et al. Among authors: grande e. Endocr Relat Cancer. 2012 Apr 10;19(2):209-16. doi: 10.1530/ERC-11-0351. Print 2012 Apr. Endocr Relat Cancer. 2012. PMID: 22285864

5

Thyroid cancer: molecular aspects and new therapeutic strategies.

Grande E, Díez JJ, Zafon C, Capdevila J. Grande E, et al. J Thyroid Res. 2012;2012:847108. doi: 10.1155/2012/847108. Epub 2012 Jul 12. J Thyroid Res. 2012. PMID: 22848860 Free PMC article.

6

The targeted therapy revolution in neuroendocrine tumors: in search of biomarkers for patient selection and response evaluation.

De Dosso S, Grande E, Barriuso J, Castellano D, Tabernero J, Capdevila J. De Dosso S, et al. Among authors: grande e. Cancer Metastasis Rev. 2013 Dec;32(3-4):465-77. doi: 10.1007/s10555-013-9421-0. Cancer Metastasis Rev. 2013. PMID: 23589060 Review.

7

Vandetanib in advanced medullary thyroid cancer: review of adverse event management strategies.

Grande E, Kreissl MC, Filetti S, Newbold K, Reinisch W, Robert C, Schlumberger M, Tolstrup LK, Zamorano JL, Capdevila J. Grande E, et al. Adv Ther. 2013 Nov;30(11):945-66. doi: 10.1007/s12325-013-0069-5. Epub 2013 Nov 19. Adv Ther. 2013. PMID: 24249433 Free PMC article. Review.

8

Systemic therapeutic strategies for GEP-NETS: what can we expect in the future?

Raymond E, García-Carbonero R, Wiedenmann B, Grande E, Pavel M. Raymond E, et al. Among authors: grande e. Cancer Metastasis Rev. 2014 Mar;33(1):367-72. doi: 10.1007/s10555-013-9467-z. Cancer Metastasis Rev. 2014. PMID: 24375390 Review.

9

A significant response to sunitinib in a patient with anaplastic thyroid carcinoma.

Grande E, Capdevila J, Díez JJ, Longo F, Carrato A. Grande E, et al. J Res Med Sci. 2013 Jul;18(7):623-5. J Res Med Sci. 2013. PMID: 24516498 Free PMC article.

10

What could Nintedanib (BIBF 1120), a triple inhibitor of VEGFR, PDGFR, and FGFR, add to the current treatment options for patients with metastatic colorectal cancer?

Capdevila J, Carrato A, Tabernero J, Grande E. Capdevila J, et al. Among authors: grande e. Crit Rev Oncol Hematol. 2014 Nov;92(2):83-106. doi: 10.1016/j.critrevonc.2014.05.004. Epub 2014 May 14. Crit Rev Oncol Hematol. 2014. PMID: 24924525 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

335 results

Search Page